China's Innogen expects to complete weight-loss drug trials next year – Reuters

  1. China’s Innogen expects to complete weight-loss drug trials next year  Reuters
  2. Novel GLP-1 Agonist Promotes Safe and Effective Weight Loss  Medscape
  3. Chinese Biotech Showcases Challenger to Eli Lilly’s Obesity Drug  Bloomberg
  4. Data from the Phase 2 Clinical Trial of CX11/VCT220 in China Presented at ADA 2025  GlobeNewswire
  5. ADA: Ecnoglutide Yields Superior, Sustained Reduction in Body Weight  Endocrinology Advisor

Continue Reading